Active substanceLevocarnitineLevocarnitine
Similar drugsTo uncover
  • Carnithen
    solution inwards 
  • Carnithen
    solution in / in 
  • Carnithen
    pills inwards 
  • L-Carnitine Rompharm
    solution w / m in / in 
  • Levocarnil®
    solution inwards 
    EVALAR, CJSC     Russia
  • Nephrocaritoneum
    solution inwards 
  • Elkar®
    solution w / m in / in 
    PIK-PHARMA, LLC     Russia
  • Elkar®
    solution inwards 
    PIK-PHARMA, LLC     Russia
  • Elkar®
    solution inwards 
    PIK-PHARMA, LLC     Russia
  • Elkar®
    granules inwards 
    PIK-PHARMA, LLC     Russia
  • Dosage form: & nbspchewing tablets
    Composition:

    One tablet contains:

    Active substance: Levocarnitine 1 g

    Auxiliary components: mint flavor, flavor liquorice, sucrose, magnesium stearate.

    Description:Flat round tablets are white or almost white in color.
    Pharmacotherapeutic group:Metabolic means
    ATX: & nbsp

    A.16.A.A   Amino acids and their derivatives

    A.16.A.A.01   Levocarnitine

    Pharmacodynamics:

    Levokarnitin - a remedy for the correction of metabolic processes. This is a natural substance related to vitamins of group B.Participates in metabolic processes as a carrier of fatty acids through cell membranes from the cytoplasm to the mitochondria, where these acids undergo oxidation with the formation of a large amount of energy (in the form of ATP). It normalizes protein and fat metabolism, restores alkaline blood reserves, inhibits the formation of keto acids and anaerobic glycolysis, reduces the degree of lactic acidosis, and also increases motor activity and increases the tolerance of exercise, while contributing to the economical consumption of glycogen and its increase in the liver.

    Indications:

    Primary and secondary deficiency of carnitine. Disturbance of metabolism in the myocardium in the case of ischemic cardiopathy: angina, postinfarction.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Carefully:In patients with diabetes mellitus.
    Pregnancy and lactation:

    The drug can be used both during pregnancy and during lactation.

    Dosing and Administration:

    Inside.

    Primary and secondary deficiency in genetic diseases:

    Daily oral dose, depending on age and body weight: from 3-6 years - 100 mg per kg of body weight,from 6 to 12 years - 75 mg per kg of body weight, from 12 years and adults - 2-4 grams, depending on the severity of the pathology and the doctor's recommendations.

    Secondary deficiency in hemodialysis: 2-4 g per day.

    Angina pectoris and postinfarction states: 2-6 g per day according to the doctor's recommendation.

    Take the drug regardless of food.

    Side effects:

    Possible mild gastrointestinal disorders (pain in epigastrium, flatulence, diarrhea, constipation) after ingestion, allergic reactions. Muscular weakness was noted in patients suffering from uremia. If any undesirable effect is not described in the instructions for use, it is necessary to contact your doctor in time.

    Overdose:Toxic manifestations due to an overdose of levocarnitine have not been established.
    Interaction:Glucocorticosteroid preparations contribute to the accumulation of the drug in the tissues.
    Special instructions:

    The administration of levocarnitine to patients suffering from diabetes mellitus and taking insulin or other oral hypoglycemic agents may lead to the development of hypoglycemia due to improved glucose uptake.Therefore, these patients should monitor the blood glucose level for timely correction of the dose of hypoglycemic drugs.

    There are no cases of habituation or metabolic dependence.

    Form release / dosage:Chewable tablets 1 g.
    Packaging:

    2 tablets in A1-strip. For 5 strips in a cardboard box with instructions for use.

    Storage conditions:

    Store at a temperature not higher than 25 ° C, out of the reach of children.

    Shelf life:

    3 years. Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N011461 / 01
    Date of registration:18.03.2008
    Expiration Date:Unlimited
    The owner of the registration certificate:Sigma-Tau United Pharmaceutical Industries SpASigma-Tau United Pharmaceutical Industries SpA Italy
    Manufacturer: & nbsp
    Representation: & nbspPharma Riace Co., Ltd. Pharma Riace Co., Ltd. United Kingdom
    Information update date: & nbsp14.12.2017
    Illustrated instructions
      Instructions
      Up